AGP Executive Report
Last update: 7 hours agoSwedish Biotech: Spago Nanomedical plans to delist and seek private funding for further trials of a drug for rare salivary gland cancer, citing difficulty raising enough capital on the stock market. Winter Safety: As Sweden’s dark season sets in, reflectors can make pedestrians visible to drivers from about 125 metres away, compared with just 20–30 metres in dark clothing. Mental Health Research: A Karolinska study finds that difficulty reading others’ emotions is linked to violence risk among people with psychosis and a history of aggression. Weight-Loss Drugs: A safety review weighs established and uncertain risks of GLP-1 medicines as use grows; about 5% of Swedish adults had filled a prescription by 2025. Youth Wellbeing: Eurostat data put Sweden near the bottom of the EU for 16–29-year-olds rating their health as good or very good, at 74.4%; the measure also reflects psychological wellbeing and reporting habits.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.